BT-GSI
BT-GSI is a bone-targeting γ-secretase inhibitor that blocks Notch signaling. It demonstrates dual anti-myeloma and anti-resorptive activity in research, showing potential to inhibit tumor progression and osteolytic lesions in preclinical models of multiple myeloma and bone metastatic disease.
Product Specifications
Field of Research
Neuroscience, Protein Biochemistry, Stem Cell & Developmental Biology
Smiles
CC[C@H] (C) [C@@H] (C (=O) N[C@@H] (CC (C) C) /C=N/N (C) CCCC (=O) NC (P (=O) (O) O) P (=O) (O) O) NC (=O) OCC1=CC=CC=C1.Br
Molecular Formula
C26H46BrN5O10P2
Molecular Weight
730.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TXB-00240-01 100 mg
P-Nitrophenyl 2-O- (α-L-fucopyranosyl) -β-D-galactopyranoside
Sign In for Pricing
View Details TXB-00240-02 250 mg
P-Nitrophenyl 2-O- (α-L-fucopyranosyl) -β-D-galactopyranoside
Sign In for Pricing
View Details TXB-00240-03 50 mg
P-Nitrophenyl 2-O- (α-L-fucopyranosyl) -β-D-galactopyranoside
Sign In for Pricing
View Details 
ZDA94402 2.5 g
2- (1-Benzylpiperidin-4-yl) acetic acid hydrochloride
Sign In for Pricing
View Details 
PB10054-Cy3 100 µg/Vial
Anti-CXCL16 Antibody Picoband® (Cy3 Conjugate)
Sign In for Pricing
View Details